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Summary 
Caspases are best characterized for their function in apoptosis. However, they also have non-
apoptotic functions such as apoptosis-induced proliferation (AiP) where caspases release 
mitogens for compensatory proliferation independently of their apoptotic role. Here, we report 
that the unconventional myosin, Myo1D, which is known for its involvement in left/right 
development, is an important mediator of AiP in Drosophila. Mechanistically, Myo1D 
translocates the initiator caspase Dronc to the basal side of the plasmamembrane of epithelial 
cells where Dronc promotes the activation of the NADPH-oxidase Duox for ROS generation and 
AiP in a non-apoptotic manner. We propose that the basal side of the plasmamembrane 
constitutes a non-apoptotic compartment for caspases. Finally, Myo1D promotes tumor growth 
and invasiveness of the neoplastic scrib RasV12 model. Together, we identified a novel function 
of Myo1D for AiP and tumorigenesis, and reveal a mechanism by which cells sequester 
apoptotic caspases in a non-apoptotic compartment at the plasmamembrane. 
 
 
Keywords: Apoptosis-induced proliferation, Drosophila, Dronc, Myo1D, non-apoptotic 
functions, plasmamembrane 
 
 
  
3 
 
Introduction 
Under stress conditions when a large number of cells are dying, there is a need for 
compensatory proliferation to replace the lost cells with new cells. Work using several model 
organisms has shown that under these conditions, apoptotic cells can release mitogenic signals 
that induce proliferation of surviving cells for the replacement of dying cells (Chera et al., 2009; 
Huh et al., 2004; Li et al., 2010; Perez-Garijo et al., 2004; Ryoo et al., 2004; Tseng et al., 2007). 
Because apoptotic cells are actively triggering this type of compensatory proliferation, this 
process has been termed apoptosis-induced proliferation (AiP) (Mollereau et al., 2013). 
Caspases are Cys proteases that are the main effectors of apoptosis (reviewed by 
(Salvesen et al., 2016; Shalini et al., 2015)). They are produced as inactive zymogens with a 
prodomain and after processing a large and small subunit. There are initiator and effector 
caspases. Initiator caspases carry protein/protein interacting motifs in their prodomains which 
mediate their incorporation into large multimeric protein complexes. For example, the 
mammalian initiator Caspase-9 is recruited into the Apaf-1 apoptosome, while its Drosophila 
ortholog Dronc forms the apoptosome with the Apaf-1 homolog Dark (reviewed by (Yuan and 
Akey, 2013)). Effector caspases such as mammalian Caspase-3 or Drosophila DrICE and Dcp-1 
are proteolytically processed by activated initiator caspases and mediate the apoptotic process.  
In addition to apoptosis, caspases are also mediating AiP. They trigger the release of 
Wnt, BMP/TGF-β, EGF and Hh mitogens for AiP (Chera et al., 2009; Fan and Bergmann, 
2008a, b, 2014; Huh et al., 2004; Li et al., 2010; Perez-Garijo et al., 2004; Ryoo et al., 2004). 
This has been best studied for the Drosophila initiator caspase Dronc using the “undead” AiP 
model in which apoptotic signaling is induced by expression of upstream cell death factors such 
as hid, but the execution of apoptosis is blocked by co-expression of the effector caspase 
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inhibitor p35, thus rendering cells in an “undead” condition (Martin et al., 2009). Because P35 
inhibits apoptosis, but not Dronc, Dronc can still mediate non-apoptotic functions such as AiP. 
When hid and p35 are co-expressed using the ey-Gal4 driver (ey>hid,p35) which is expressed in 
epithelial cells of eye imaginal discs, Dronc continuously signals for AiP and triggers hyper-
proliferation. Consequently, the discs are enlarged and the resulting heads of the adult flies are 
overgrown (the phenotypic classes of ey>hid,p35-induced overgrowth are shown in Figure S1A-
D). In genetic screens, we are screening for suppressors of the overgrowth phenotype of undead 
(ey>hid,p35) adult heads to identify genes and mechanisms involved in AiP (Fan et al., 2014).  
Mechanistically, we showed that in undead cells, Dronc stimulates the NADPH-oxidase 
Duox for the production of extracellular reactive oxygen species (eROS) (Fogarty et al., 2016). 
eROS recruit and activate hemocytes, Drosophila immune cells similar to macrophages, to the 
undead imaginal disc. In turn, hemocytes release the TNF-like ligand Eiger which induces JNK 
activity in epithelial disc cells. JNK promotes the expression of the apoptotic genes reaper and 
hid which initiate a positive feedback loop to maintain undead signaling (Fogarty et al., 2016). In 
addition, it induces the release of the mitogens Wingless (Wg), a Wnt-like gene in Drosophila, 
Decapentaplegic (Dpp), a BMP/TGF-β homolog and Spitz (Spi), an EGF ligand (Fan et al., 
2014; Huh et al., 2004; Perez-Garijo et al., 2004; Ryoo et al., 2004) which all promote AiP.  
In addition to undead AiP, there is also “genuine” AiP during which dying cells complete 
the apoptotic process and the response of the affected tissue to replace the dying cells is 
examined (Fan and Bergmann, 2008b; Fan et al., 2014; Herrera et al., 2013; Santabarbara-Ruiz 
et al., 2015; Smith-Bolton et al., 2009). In contrast to undead AiP, genuine AiP does not promote 
overgrowth. Therefore, although most genes identified in undead AiP also have important roles 
in genuine AiP, there must be differences between the two AiP models. In any case, genuine AiP 
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is used as a model of tissue regeneration, while the hyper-proliferation of undead AiP serves as a 
tumorigenic model (reviewed in (Fogarty and Bergmann, 2015, 2017)). 
Class I unconventional myosins are conserved actin-based motor proteins, composed of 
the N-terminal head (motor) region with an ATP-binding motif (including P-, switch1- and 
switch2-loops) and an actin-binding domain, a neck region characterized by two to three IQ 
motifs and a C-terminal tail domain that interacts with phospholipids at membranes (Figure 2A) 
(reviewed in (Barylko et al., 2000; Coluccio, 1997)). Mammals have eight class I myosins, 
Drosophila has three, Myosin 1D (Myo1D, aka Myo31DF), MyoIC (Myo61F) and Myo95E 
(Morgan et al., 1995; Morgan et al., 1994; Okumura et al., 2015; Tzolovsky et al., 2002). While 
Myo1D and Myo1C are involved in left/right (L/R) development of visceral organs, the function 
of Myo95E is unknown (Hozumi et al., 2006; Okumura et al., 2015; Speder et al., 2006). 
Although Drosophila is a bilateral organism, certain visceral organs such as the gut and 
the coiling of the spermiducts around the gut which occurs in a morphogenetic movement termed 
male terminalia rotation, display L/R asymmetry (Coutelis et al., 2014; Geminard et al., 2014; 
Hayashi and Murakami, 2001; Kuranaga et al., 2011; Ligoxygakis et al., 2001; Petzoldt et al., 
2012; Speder et al., 2006; Suzanne et al., 2010). In Myo1D mutants, the chirality of these 
asymmetric organs and movements are reversed (Hozumi et al., 2006; Speder et al., 2006). For 
example, the male terminalia rotation during pupal development which in wild-type occurs for 
360° in clockwise (dextral) orientation, proceeds in Myo1D mutants sinistrally, defining Myo1D 
as dextral determinant (Hozumi et al., 2006; Speder et al., 2006). Myo1D engages the actin 
cytoskeleton and adherens junctions for this movement (Petzoldt et al., 2012). 
Overexpression of Myo1C antagonizes the dextral activity of Myo1D by displacing it 
from adherens junctions (Hozumi et al., 2008; Petzoldt et al., 2012). However, the loss-of-
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function phenotype of Myo1C did not confirm this antagonizing function. Instead, while Myo1C 
single mutants do not display any L/R defect, the Myo1C Myo1D double mutant has a stronger 
sinistral male terminalia phenotype than Myo1D mutants indicating that Myo1C has a partially 
redundant dextral activity with Myo1D (Okumura et al., 2015). 
It has long been known that genes in the apoptosis pathway such as hid, dronc and drICE 
are also involved in male terminalia rotation in Drosophila (Abbott and Lengyel, 1991; Grether 
et al., 1995; Kamber Kaya et al., 2017; Krieser et al., 2007; Macias et al., 2004; Muro et al., 
2006). Indeed, localized apoptotic activity is required for this L/R process (Kuranaga et al., 2011; 
Suzanne et al., 2010). How Myo1D and the apoptosis pathway interact for male terminalia 
rotation is not very well understood. Interestingly, mutants of the JNK signaling pathway or 
overexpression of puckered, an inhibitor of JNK activity, also display defects in male terminalia 
rotation (Glise et al., 1995; Holland et al., 1997; Macias et al., 2004; Rousset et al., 2010).  
Here, we report that Myo1D is an essential component of AiP in the undead model. 
Genetic inactivation of Myo1D strongly suppresses ey>hid,p35-induced overgrowth of the head 
capsule, while overexpression of Myo1D enhances it. Myo1D promotes the generation of ROS 
by Duox for AiP signaling. Further mechanistic analysis reveals that Myo1D is required for 
membrane localization of Dronc, specifically to the basal side of the plasmamembrane of undead 
epithelial disc and salivary gland cells. Here, Dronc exerts a non-apoptotic function resulting in 
Duox activation. We propose that the basal side of the plasmamembrane constitutes a non-
apoptotic compartment which allows non-apoptotic processes of Dronc and potentially other 
caspases to occur. Therefore, in addition to the dextral activity of Myo1D, we identified a novel 
function of Myo1D for the control of apoptosis-induced proliferation. 
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Results 
Myo1D is necessary and sufficient for generation of ROS in undead tissue 
In a RNAi modifier screen, we identified two independent Myo1D RNAi lines as strong 
suppressors of ey>hid,p35-induced head overgrowth (Figure 1A-F). In addition, two Myo1D 
mutant alleles dominantly suppressed ey>hid,p35-induced overgrowth (Figure 1A,G,H). 
Conversely, mis-expression of Myo1D strongly enhanced ey>hid,p35-induced overgrowth 
(Figure 1A,I). A control UAS line (UAS-EV) did not modify AiP-overgrowth (Figure 1A,D). 
To determine how Myo1D controls AiP, we first considered that it may control AiP 
indirectly through regulation of apoptosis. However, Myo1D RNAi does not significantly change 
apoptosis in two apoptosis models in the eye (GMR-hid) and wing (nub-hid) imaginal discs 
(Figure S1E-I’) suggesting that Myo1D does not affect cell death, but is directly involved in 
driving proliferation of AiP. 
To identify the step in which Myo1D is involved in the AiP pathway, we tested the 
dependence of several AiP markers on Myo1D. Indeed, Myo1D RNAi suppressed ectopic JNK 
activity and Wg expression in undead tissue (Figure 1J-L’; Figure S1J-K’) suggesting that 
Myo1D acts upstream of these markers. Because JNK activity is induced by Eiger signaling in 
the undead model (Fogarty et al., 2016), we examined if Myo1D is involved in Eiger signaling 
using the GMR>Eiger model. However, Myo1D RNAi does not suppress GMR-Eiger-induced 
eye ablation (Figure S2), suggesting that Myo1D is not part of the Eiger signaling pathway.  
Recently, we showed that undead AiP involves ROS generation and activation of 
hemocytes (Fogarty et al., 2016). In control eye/antennal discs, hemocytes form cellular clusters 
at the antennal disc and along the morphogenetic furrow of the eye disc (Figure 1M,M’). 
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However, at undead eye discs, hemocytes cover large portions of the eye discs, single out from 
the cellular clusters and extend cytoplasmic protrusions in an ROS-dependent manner (Figure 
1N,N’,P) (Fogarty et al., 2016). Depletion of Myo1D results in the failure of the hemocytes to 
adopt the activated morphology (Figure 1O,O’,P). In addition, reducing Myo1D activity causes 
loss of DHE labeling, a ROS indicator (Figure 1Q-T). These data place Myo1D upstream of 
ROS generation in the AiP pathway (Figure 1U). 
While overexpression of Myo1D by ey-Gal4 does not induce any obvious phenotypes, in 
ey>p35 eye discs it is sufficient to induce head capsule overgrowth (Figure 1V-X). Consistently, 
this is accompanied by the generation of ROS and hemocyte activation (Figure 2G,Q) as well as 
JNK activity and Wg expression (Figure S3). Taken together, under undead conditions, Myo1D 
is both necessary and sufficient for production of ROS which leads to activation of hemocytes, 
JNK and Wg signaling, resulting in AiP and tissue overgrowth. 
 
The head, IQ and tail domains of Myo1D are required for ROS generation and AiP 
As a myosin, Myo1D contains head (motor), neck (IQ) and tail regions (Figure 2A). We 
examined which domains of Myo1D function in AiP-induced overgrowth and tested Myo1D 
transgenes which mutate critical residues in the head region or delete neck and tail domains 
(Hozumi et al., 2008). Although these mutant transgenes are not expressed at comparable levels 
in ey>hid,p35 background (Figure S4K), we were still able to obtain meaningful results. While 
expression of Myo1Dwt strongly enhanced ey>hid,p35–induced head overgrowth (Figure 1I; 
Figure 2B, genotype 2), expression of constructs that mutate the ATP binding site (Myo1DmATP-
bs) or delete the Actin-binding site (Myo1DΔActin-bs) in the head region did not enhance 
ey>hid,p35-induced overgrowth (Figure 2B, genotypes 3,4) suggesting that the ATP-
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hydrolyzing and Actin-binding activities of Myo1D are required for AiP-induced overgrowth. 
Strikingly, expression of Myo1D constructs that delete the neck (IQ) (Myo1DΔIQ) and tail 
(Myo1DΔtail) regions acted as strong suppressors of ey>hid,p35-induced overgrowth (Figure 2B, 
genotypes 5,6; Figure S4A-C) suggesting that these deletion constructs act as dominant negative 
alleles of Myo1D. These results imply that the IQ and tail domains of Myo1D play critical roles 
in AiP-induced overgrowth. Consistently, expression of Myo1DΔIQ in ey>hid,p35 eye discs 
blocked the generation of ROS and the activation of hemocytes (Figure 2D,E,L,M).  
Similar results were obtained when these transgenes were expressed in ey>p35 discs. 
While expression of Myo1Dwt in ey>p35 discs triggers overgrowth (Figure 1W,X), Myo1DΔIQ 
and Myo1DΔtail fail to do so (Figure S4G-J). Consistently, these mutant transgenes were unable to 
promote ROS generation and to activate hemocytes in ey>p35 background (Figure 2H,R,S). 
We also examined the ability of Myo1Dwt, Myo1DΔIQ and Myo1DΔtail transgenes to rescue 
(revert) the suppression of ey>hid,p35-induced overgrowth by Myo1DK2 and Myo1DEy08899 
mutants (Figure 1A,G,H). As expected, expression of Myo1Dwt strongly reverts the suppression 
of ey>hid,p35 by Myo1DK2 and Myo1DEy08899 mutants (Figure 2C, genotypes 3,4,7,8). In 
contrast, Myo1DΔIQ and Myo1DΔtail transgenes were not able to do so (Figure 2C, genotypes 
5,6,9,10), providing further evidence for the critical role of the neck (IQ) and tail domains for 
Myo1D’s function in AiP. 
We also tested if expression of the second class I myosin, Myo1C, has a similar 
antagonistic function towards Myo1D for AiP as reported for L/R development (Hozumi et al., 
2008; Petzoldt et al., 2012). Indeed, overexpression of Myo1C in ey>hid,p35 discs weakly 
suppressed head capsule overgrowth and blocked generation of ROS and hemocyte activation 
(Figure 2B, genotype 7; Figure 2F,N; Figure S4D). Furthermore, ROS generation and hemocyte 
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activation by Myo1D in ey>p35 discs is suppressed by simultaneous Myo1C expression (Figure 
2I,T,U). These data support the notion that similar to L/R development, overexpression of 
Myo1C behaves in an antagonistic manner towards Myo1D in AiP. 
Myo1D and Myo1C have a very similar domain structure (Morgan et al., 1995; Morgan 
et al., 1994; Okumura et al., 2015). We tested chimeras which swap the head with the neck (IQ) 
and tail regions of both proteins (Myo1CH-1DIQ-tail and Myo1DH-1CIQ-tail) (Hozumi et al., 2008) 
in the undead AiP model. Myo1CH-1DIQ-tail strongly enhances the overgrowth phenotype of 
ey>hid,p35 flies similar to overexpression of Myo1Dwt (Figure 2B, genotype 8; Figure S4E). In 
contrast, the reverse chimera (Myo1DH-1CIQ-tail) weakly suppressed the overgrowth phenotype 
(Figure 2B, genotype 9; Figure S4F). Consistently, expression of Myo1CH-1DIQ-tail in ey>hid,p35 
eye discs resulted in strong hemocyte activation at eye discs, while Myo1DH-1CIQ-tail blocked 
hemocyte activation (Figure 2O,P). These data suggest that while the head (motor) domain is 
interchangeable between Myo1D and Myo1C, the specificity of Myo1D for overgrowth-
promoting AiP lies in the neck (IQ) and tail domains of Myo1D. 
 
Genetic and physical interaction between Myo1D and Dronc 
Our observation that reduced Myo1D activity causes loss of ROS places Myo1D 
genetically between the initiator caspase Dronc and the NADPH oxidase Duox in the AiP 
pathway (Figure 1S,U). Therefore, we examined for a genetic and physical interaction between 
Dronc and Myo1D. While mis-expression of Dronc and Myo1D alone causes weak overgrowth 
of ey>p35 head capsules, co-expression of both genes triggers very strong overgrowth (Figure 
3A-D) suggesting that they genetically interact.  
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Therefore, we tested if the two proteins also physically interact. Because available 
Myo1D-specific antibodies failed in immunoprecipitation experiments, we expressed a Myo1D-
GFP fusion protein in ey>hid,p35 discs and immunoprecipitated Myo1D-GFP with GFP-
conjugated beads. These immunoprecipitates contained endogenous Dronc protein (Figure 3E). 
In reverse experiments, we detected HA-tagged Myo1D in immunoprecipitates of Flag-Dronc 
from eye disc extracts (Figure 3F) suggesting that Myo1D and Dronc form a protein complex. 
Because of the physical interaction, we considered that Myo1D is a proteolytic target of 
the caspase Dronc. However, while active Dronc is able to process its known substrate DrICE in 
cleavage assays in vitro, there is no detectable proteolytic event with Myo1D (Figure 3G). 
Furthermore, in immunoblots of protein extracts from undead ey>hid,p35,Myo1D-GFP eye 
discs, we did not detect a cleavage product of Myo1D-GFP even in the presence of an additional 
dronc transgene (Figure 3H). Therefore, although Dronc and Myo1D genetically and physically 
interact, Myo1D does not appear to be a proteolytic target of Dronc in undead cells. 
 
Myo1D is required for membrane localization and stabilization of Dronc 
To examine the physiological significance of the Dronc/Myo1D interaction, we 
performed immunolocalization studies of the two proteins in eye-antennal imaginal discs from 
3rd instar larvae. The eye-antennal imaginal disc is composed of two epithelial sheets, the 
columnar cells of the disc proper (DP) and the squamous cells of the peripodial membrane (PM), 
that form a sac-like structure separated by a lumen (Figure 4A). In the following, we present the 
immunolocalization data in orthogonal sections as illustrated on the right of Figure 4A. In cells 
of control (ey-Gal4) eye imaginal discs, endogenous Myo1D is strongly expressed in PM cells 
and enriched at the basal side of the plasmamembrane of DP cells (Figure 4B; arrows). 
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Endogenous Dronc protein is also strongly expressed in PM cells, while in DP cells, it is present 
in the cytosol with a weak plasmamembrane localization at the basal side of the disc (Figure 
4B’). Myo1D RNAi disrupts the membrane localization of Dronc (Figure 4C’). Importantly, in 
undead ey>hid,p35 discs, endogenous Dronc protein becomes strongly enriched at the 
plasmamembrane of DP cells (Figure 4D’). Co-labeling with the polarity marker Dlg suggests 
that Dronc is specifically localized to the basal side of the plasmamembrane in DP cells 
matching the localization of Myo1D (Figure 4D). This membrane localization is dependent on 
Myo1D, because in ey>hid,p35 discs expressing Myo1D RNAi, Dronc protein loses the 
membrane localization (Figure 4E’). These differences in the localization of Dronc to the basal 
side of the plasmamembrane of DP cells are quantified in Figure 4F. Furthermore, Myo1D RNAi 
appears to result in a reduction of the protein level of Dronc (Figure 4F’) suggesting that 
Myo1D-dependent membrane localization also stabilizes Dronc protein in undead cells. This is 
confirmed by immunoblot analysis (Figure 4G). 
It was recently reported that Dronc localizes to the plasmamembrane of larval salivary 
gland (SG) cells which is dependent on another factor, Tango7 (Kang et al., 2017). SGs are 
composed of secretory, columnar epithelial cells which form a tube with a lumen inside (Andrew 
et al., 2000). The apical membranes of SG cells face the lumen, while the basal side of SG cells 
is exposed to the exterior of the gland (Figure 4H). Because the ey-Gal4 driver is also expressed 
in SG cells, we examined the dependence of the membrane localization of Dronc on Myo1D in 
SG cells. In sections (Figure 4H, bottom) of control (ey-Gal4) SG cells, endogenous Dronc 
protein localizes at the plasmamembrane consistent with (Kang et al., 2017) as does Myo1D 
(Figure 4I-I’’). Similar to eye discs, this localization occurs at the basal side of the 
plasmamembrane, as judged by co-localization with the polarity marker Dlg (Figure 4I’’,I’’’). In 
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contrast to eye discs, Myo1D RNAi does not significantly disturb the Dronc localization in 
control SG cells (Figure 4J). This is likely due to Tango7, a factor that is required for membrane 
localization of Dronc in SGs (Kang et al., 2017). Importantly, in undead (ey>hid,p35) SGs, the 
localization of endogenous Dronc to the basal side of the plasmamembrane is strongly increased 
(Figure 4K). This increased membrane localization of Dronc in undead SG cells is dependent on 
Myo1D, as Myo1D RNAi strongly reduces it (Figure 4L).  
Furthermore, ectopically targeting Myo1D-GFP to the apical surface of DP cells by co-
expression with GrabFP-AInt which traps GFP fusion proteins to the apical side of epithelial cells 
(Harmansa et al., 2017) disrupts the basal localization of Dronc protein in undead cells (Figure 
S5). Combined, these data establish that Myo1D is required for localization of Dronc to the basal 
side of the plasmamembrane of undead epithelial and SG cells. 
In ey>hid,p35 eye imaginal discs, mis-expression of Myo1Dwt also triggers strong 
enrichment of endogenous Dronc at the basal plasmamembrane of DP cells (Figure 4M,M’). In 
Figure 2, we established that the neck (IQ) and tail domains of Myo1D determine its specificity 
in AiP. Therefore, we examined the role of the IQ and tail domains for membrane localization of 
both Dronc and Myo1D. The localization of Dronc to the basal membrane is at least partially lost 
by expression of Myo1DΔIQ and Myo1DΔtail (Figure 4P-O’). Although Myo1DΔIQ is expressed in 
very low levels by ey-hid,p35 (Figure S4K), the protein levels of Dronc at the plasmamembrane 
are strongly reduced (Figure 4N,N’; quantified in Figure 4P). Myo1DΔtail has lost its membrane 
association completely and consequently Dronc has a large cytosolic localization (Figure 
4O,O’;P). These findings suggest that the IQ domain of Myo1D is involved in the interaction 
with Dronc, while the tail domain mediates the association with the plasmamembrane. 
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Because the adaptor protein Dark recruits Dronc into the apoptosome during apoptosis, 
we analyzed the subcellular localization of Dark in SGs. Because of the lack of suitable Dark 
antibodies, we expressed a GFP-tagged Dark (Dark-GFP) construct in SGs and examined the 
localization of Dark-GFP using a GFP antibody. In contrast to Dronc protein, the overall 
localization of Dark-GFP does not change in undead SGs and is not dependent on Myo1D 
(Figure S6A-C). Although there is a membrane-associated component of Dark-GFP, it is largely 
cytosolic and there is only very weak colocalization with Dronc in undead SGs (Figure S6D). 
Therefore, the sequestration of Dronc to the basal side of the plasmamembrane may suggest a 
mechanism by which Dronc is largely separated from its apoptotic partner Dark. 
 
Membrane-localized Dronc triggers non-apoptotic caspase activity at the membrane 
In normal apoptotic cells of imaginal discs, Dronc triggers caspase activation in the 
cytosol as visualized by cleaved caspase (CC3) antibody labeling both in surface views and in 
orthogonal sections (Figure 5A). Therefore, we examined if membrane-localized Dronc in 
undead cells is also able to trigger CC3 labeling. Indeed, in undead (ey>hid,p35) eye discs, we 
detect CC3 labeling and similar to Dronc, it is largely localized at the plasmamembrane, 
overlapping with Myo1D (Figure 5B-B’’). In orthogonal sections, CC3 is localized to PM cells 
as well as to the basal plasmamembrane of undead DP cells, similar to Myo1D (Figure 
5B’’’,5B’’’’) and Dronc (Figure 4D). In undead wing imaginal discs (nub>hid,p35), we also 
observe a membrane localization of CC3 at the basal side of DP cells (Figure S1I, inset). The 
membrane localization of CC3 labeling in undead DP cells is dependent on Myo1D as Myo1D 
RNAi disrupts the localized labeling of CC3 at the plasmamembrane (Figure 5C) consistent with 
the dependence of Dronc on Myo1D for membrane localization (Figure 4E). 
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Likewise, in undead (ey>hid,p35) SG cells, there is enriched CC3 labeling at the basal 
side of the plasmamembrane (Figure 5D’,D’’’). Even under normal conditions (without 
expression of hid and p35), can we detect membrane-localized CC3 labeling in SG cells (Figure 
5F,F’), but it is much weaker than in undead cells. Knockdown of Myo1D strongly reduces CC3 
labeling at the plasmamembrane of both normal and undead SG cells (Figure 5E,G) suggesting 
that Myo1D is required for Dronc activity at the plasmamembrane.  
Interestingly, the SGs analyzed in Figure 5D,E were obtained from 3rd instar larvae and 
are not apoptotic at that stage. That raises the possibility that the caspase activity at the 
plasmamembrane is non-apoptotic in nature. To examine this possibility, we employed 
differential labeling specificities of CC3 and cleaved Dcp1 (cDcp1) antibodies. We have 
previously shown that CC3 labeling detects both apoptotic and non-apoptotic activity of Dronc 
(Figure 5H) (Fan and Bergmann, 2010). Consistently, membrane-localized CC3 labeling in SGs 
is completely dependent on Dronc, as it disappears in homozygous dronc mutants (Figure 5I). In 
contrast to CC3 antibody, the cDcp1 antibody was raised to specifically detect a neo-epitope of 
Dcp1 after Dronc cleavage and is a more specific marker for Dronc’s apoptotic activity (Figure 
5H). dcp1;drICE double null mutants completely lack apoptosis (Fan and Bergmann, 2010) and 
consistently, these double mutant SGs do not label with the cDcp1 antibody (Figure 5J). In 
contrast, membrane-localized CC3 labeling is still present in dcp1;drICE double null SGs 
(Figure 5K), further supporting the notion that the membrane localized CC3 activity is non-
apoptotic. Combined, these data demonstrate that membrane-localized Dronc has a non-apoptotic 
activity and suggest that the plasmamembrane, specifically the basal side of the 
plasmamembrane, acts as a non-apoptotic compartment. 
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Myo1D-induced ROS generation depends on the NADPH oxidase Duox and Dronc 
We showed previously that Duox generates eROS in the undead AiP model which is 
required for hemocyte recruitment and overgrowth (Fogarty et al., 2016). We therefore examined 
if Myo1D’s ability to induce ROS generation, hemocyte recruitment and overgrowth of 
ey>p35,Myo1D flies (Figure 6A-C) is dependent on Duox. Indeed, knockdown of Duox 
suppresses ROS production, hemocyte activation and overgrowth of ey>p35,Myo1D eye discs 
(Figure 6D-F; quantified in G,H) suggesting that Duox mediates the overgrowth-promoting 
function of Myo1D.  
We also found that endogenous Duox and Dronc proteins co-localize at the basal side of 
the plasmamembrane of undead DP cells in imaginal discs and SG cells (Figure 6I-N). 
Excitingly, while Duox mis-expression alone is unable to induce ROS in ey>p35 epithelial cells, 
co-expression of Duox and Myo1D strongly increases the ability of Duox to generate ROS 
(Figure 6O-R; quantified in 6S). These findings suggest that Myo1D directly or indirectly 
promotes the activation of Duox for eROS generation. 
Interestingly, reduction of dronc activity by RNAi in ey>p35 eye discs suppresses both 
Myo1D-induced overgrowth and ROS generation (Figure 6T,U; compare to Figure 6A,B,Q). 
This result suggests that Dronc has an important function at the plasmamembrane for ROS 
generation and AiP, and that Myo1D enables Dronc to exert this function by localizing it to the 
membrane. 
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Myo1D is required for neoplastic growth of scrib-/-RasV12 through control of ROS 
production 
Recently, we showed that neoplastic growth and invasive behavior of epithelial scrib-/-
RasV12 disc cells in Drosophila is dependent on caspase-generated ROS (Perez et al., 2017). 
Furthermore, in the presence of RasV12, scrib-/- and other tumor cells acquire undead properties 
(Hirabayashi et al., 2013; Perez et al., 2017). Therefore, given the involvement of Myo1D in 
ROS generation and overgrowth in the undead AiP model, we examined if Myo1D is required for 
the neoplastic phenotype of scrib-/-RasV12. In mosaic eye imaginal discs, scrib-/-RasV12 clones 
occupy up to 90% of the tissue (Figure 7A,C) (Brumby and Richardson, 2003; Pagliarini and Xu, 
2003). Reducing Myo1D levels by RNAi significantly reduces the size of scrib-/- RasV12 clones 
(Figure 7B,C). Furthermore, scrib-/- RasV12 cells from eye discs display metastatic behavior and 
invade distant tissue such as the ventral nerve cord (VNC) in the larval brain (Figure 7D, arrow) 
(Pagliarini and Xu, 2003). Reducing Myo1D activity by RNAi suppresses the invasive behavior 
of scrib-/-RasV12 cells and normalizes their growth (Figure 7E,F). These observations suggest that 
Myo1D is required for neoplastic growth and invasive behavior of scrib-/-RasV12 mutant cells. 
Because ROS generation in scrib-/- RasV12 mosaic discs is dependent on caspases and 
Duox (Perez et al., 2017) similar to the undead AiP model, we examined ROS levels in scrib-/-
RasV12 discs after knockdown of Myo1D. Indeed, loss of Myo1D results in strong reduction of 
DHE labeling (Figure 7G-I) suggesting that Myo1D is required for ROS generation. As a 
consequence of ROS reduction, hemocytes are no longer activated and display the naïve 
morphology in scrib-/-RasV12;Myo1DRNAi mosaic discs (Figure 7J-L).  
Because we showed in the undead (ey>hid,p35) model that Dronc is localized to the 
plasmamembrane (Figure 4) and because RasV12 confers undead properties to tumor cells 
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(Hirabayashi et al., 2013; Perez et al., 2017), we examined the subcellular localization of Dronc 
in scrib-/-RasV12 mutant cells. Similar to the ey>hid,p35 model, Dronc appears to be enriched at 
the plasmamembrane in scrib-/-RasV12 mutant cells (Figure 7M,M’). Upon knockdown of Myo1D, 
the membrane localization of Dronc is disrupted and Dronc protein levels are reduced (Figure 
7N,N’). In summary, it appears that the mechanism of Myo1D function in the undead AiP and 
the neoplastic scrib-/-RasV12 models are very similar. In both cases, Myo1D translocates Dronc to 
the plasmamembrane where is stimulates Duox activation in a non-apoptotic function.  
 
Discussion 
In this paper, we identified a novel function of the class I unconventional myosin, 
Myo1D. In addition to its established function as a L/R determinant (Hozumi et al., 2006; Speder 
et al., 2006), Myo1D also plays an essential role in AiP. Mechanistically, we found that Myo1D 
is involved in the localization of the initiator caspase Dronc to the basal side of the 
plasmamembrane of undead DP disc and SG cells (Figure 4). Myo1D interacts with Dronc 
suggesting that it may directly translocate Dronc to the plasmamembrane. However, Myo1D 
does not appear to be a cleavage target of the caspase Dronc.  
The observed localization of Dronc to the basal side of the plasmamembrane in undead 
disc proper (DP) cells is critical for the mechanism of AiP. Undead cells attract hemocytes to the 
discs in a Dronc- and Duox-dependent manner (Fogarty et al., 2016). However, that occurs at the 
basal side of DP cells of imaginal discs because the basal side is exposed to the hemolymph 
which contains circulating hemocytes, while the apical side faces the lumen between the DP and 
the PM (Figure 4A). Consistently, there is also an enrichment of Duox at the basal side of the 
plasmamembrane (Figure 6I,K). Therefore, in order to be able to activate Duox for ROS 
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generation and hemocyte activation, Dronc needs to be specifically present at the basal side of 
the plasma membrane (Figure 8).  
It has long been known that caspases, including Dronc, have non-apoptotic functions in 
addition to their well characterized role in apoptosis (Aram et al., 2016; Aram et al., 2017; 
Fogarty and Bergmann, 2017; Fogarty et al., 2016; Mukherjee and Williams, 2017; Nakajima 
and Kuranaga, 2017; Shalini et al., 2015). In this paper, we reveal one mechanism by which cells 
may activate a caspase (Dronc) without the detrimental consequences of apoptosis. The 
sequestration of Dronc to the basal side of the plasmamembrane in a Myo1D-dependent manner 
and the low abundance of Dronc’s apoptotic partner Dark at the plasmamembrane (Figure S6) 
may ensure localized and controlled apoptosome activity which is sufficient for AiP, but not for 
killing cells. Alternatively, apoptotic substrates needed for the execution of apoptosis may not be 
present at the plasmamembrane or in insufficient amount to pass the apoptotic threshold.  
While we addressed the role of membrane localization of Dronc under undead conditions, 
recently membrane-localized Dronc was shown in SGs under normal conditions (Kang et al., 
2017) which explains the membrane localization of Dronc at control SGs (Figure 4I). Here, 
membrane-localized Dronc is required for F-actin cytoskeleton dismantling at the end of larval 
development in a non-apoptotic manner (Kang et al., 2017). In addition to the plasmamembrane, 
the outer mitochondrial membrane has been shown to provide a non-apoptotic platform for 
caspase activation, in this case during sperm maturation (Aram et al., 2016). Therefore, 
membranes in general may provide a local environment for non-apoptotic caspase activities. 
The membrane localization of Dronc in SGs is mediated by Tango7 which has previously 
been implicated in spermatid maturation (D'Brot et al., 2013; Kang et al., 2017). As mentioned 
above, membrane-localized Dronc is required for dismantling of cortical F-actin cytoskeleton in 
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SGs of late larvae (Kang et al., 2017). However, while Tango7 RNAi blocks actin dismantling, 
Myo1D RNAi does not (data not shown) suggesting that the roles of Tango7 and Myo1D for 
membrane-localization of Dronc are different from each other. That also explains why in undead 
SGs the membrane localization of Dronc strongly increases in a Myo1D-dependent manner 
(Figure 4K). Unfortunately, we were not able to test if Tango7 is involved in AiP. Tango7 RNAi 
in eye imaginal discs results in complete loss of the disc. Tango7 encodes the homolog of 
eukaryotic translation initiation factor 3m (eIF3m) suggesting that it may also have an important 
requirement for protein translation, explaining the loss of the eye disc by Tango7 RNAi. 
In addition to Myo1D and Tango7, there is at least one other factor, Crinkled (Ck), that 
directs Dronc to non-apoptotic functions. Ck bridges the interaction between Dronc and the 
kinase Shaggy/GSK-β, resulting in the selective activation of Shaggy/GSK-β which then 
promotes non-apoptotic activities such as the specification of scutellar bristles, border cell 
migration and correct branching of the aristae (Orme et al., 2016). Interestingly, Ck encodes 
another unconventional myosin, a member of the class VII myosin family (Orme et al., 2016) 
potentially suggesting that other myosins may also direct non-apoptotic functions to caspases. 
Myo1D and the apoptotic machinery have been linked to male terminalia rotation, a L/R 
process during pupal development (Abbott and Lengyel, 1991; Grether et al., 1995; Krieser et 
al., 2007; Macias et al., 2004; Muro et al., 2006). Indeed, apoptosis is required for Myo1D-
dependent male terminalia rotation (Kuranaga et al., 2011; Suzanne et al., 2010). It is unknown 
how Myo1D interacts with the apoptotic machinery to direct this L/R movement. In future 
studies, it will be interesting to examine if the Myo1D-dependent mechanism identified here for 
AiP also applies to male terminalia rotation or whether a separate mechanism exists in this 
context.  
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Myo1D not only localizes Dronc to the plasmamembrane, it also stabilizes it (Figure 
4E’,G). Dronc is activated in undead cells and activated Dronc is subject of increased protein 
degradation (Lee et al., 2011; Lee et al., 2016; Shapiro et al., 2008). Thus, Myo1D prevents 
degradation of Dronc by changing its subcellular localization to the plasmamembrane. 
Myo1D has a very strong requirement in AiP in the undead model, and a requirement in 
the scrib-/-RasV12 tumorigenesis model, yet it does not appear to play any significant role in 
genuine AiP (data not shown). In fact, Myo1D is the first gene identified that is essential for 
the hyper-proliferation of undead AiP, but not required for the regeneration of genuine AiP. The 
mechanism revealed in this paper provides an explanation for this behavior. During genuine AiP, 
cells are allowed to undergo apoptosis, which requires cytosolic Dronc activity. Although ROS 
are generated during genuine AiP (Santabarbara-Ruiz et al., 2015), the origin of these ROS has 
not been determined and may not require the plasmamembrane-localized Duox. Therefore, a key 
difference between genuine AiP and undead AiP, and potentially between other regenerative 
versus tumorigenic models, may be the altered localization of Dronc to a non-apoptotic 
compartment at the plasmamembrane, and a shift from balanced apoptosis and proliferation, to 
dominant proliferation. The next big question will be to examine what exactly is prompting 
Myo1D to drive this re-localization of Dronc under sustained undead conditions, but not under 
the limited regenerative conditions of the genuine AiP models, and whether that answer provides 
any insight into the cancer versus wound healing models. 
In conclusion, in addition to its role in L/R development, we identified a novel function 
of Myo1D for AiP and tumorigenesis. We also identified the basal side of the plasmamembrane 
as a non-apoptotic environment for caspase function. In future work, it will be important to 
identify the mechanisms by which Dronc mediates its non-apoptotic functions at the 
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plasmamembrane for AiP and other cellular processes that require membrane-localization of 
Dronc and other caspases. 
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Figure legends 
Figure 1. Myo1D is required for undead tissue overgrowth upstream of ROS production. 
(A) Quantification of the suppression of head overgrowth of ey>hid,p35 animals by 
Myo1D RNAi or Myo1D mutants as shown in (C-H). Displayed is also the enhancement by 
Myo1D misexpression (I). Suppression is determined based on a shift in the percentage from 
overgrown animals to wild-type. Details to statistics in this and all other figures can be found in 
STAR Methods. 50-150 flies were counted per genotype. 
(B) The head capsule of a wild type fly. Scale bar: 200μm. 
(C,D) Head capsule overgrowth of ey>hid,p35 animals (C) is not suppressed by a control 
UAS-empty vector (UAS-EV) transgene (D).  
(E-H) Representative examples of the suppression of ey>hid,p35-induced head 
overgrowth by Myo1D RNAi (E,F) and Myo1D mutants (G,H). Myo1DRNAi(KK) in (E) is VDRC 
line KK102456, Myo1DRNAi(BL) in (F) is Bloomington line BL33971. Myo1DEy in (H) is 
Myo1DEy08859. 
(I) Strong enhancement of the overgrowth phenotype of ey>hid,p35 animals by Myo1D 
misexpression. 
(J-L’) Eye imaginal discs of the indicated genotypes labeled for β-Gal (red, to visualize 
JNK activity), cleaved caspase3 (CC3, green) and ELAV (blue) which marks photoreceptor 
neurons in the posterior half of the disc. Scale bar: 50μm. 
 (M-O’) Hemocyte labeling using anti-NimrodC (NimC) antibody (Kurucz et al., 2007) 
of eye imaginal discs of indicated genotype. Arrows in (N’) indicate cytoplasmic protrusions of 
activated hemocytes. Scale bars in (N): 50μm; in (N’): 20μm. 
(P) Quantification of the NimC labelings in (M-O). NimC signal intensity was 
determined across the entire discs. 
(Q-S) DHE labeling as ROS marker of imaginal discs of the same genotypes as in (M-O). 
Scale bar: 50μm. 
(T) Quantification of DHE labelings in (Q-S). DHE signal intensity was determined 
across the entire discs.  
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(U) Schematic summary of the placement of Myo1D into the AiP pathway. 
(V-X) Misexpression of Myo1D in ey>p35 animals triggers head capsule overgrowth 
(W). Quantified in (X). 
 
Figure 2. The neck (IQ) and tail regions of Myo1D are critical for AiP 
(A) Outline of the domain structure of Myo1D. P = P-loop; s1/2 = switch1/2-loop.  
  (B) Summary of the head phenotypes of ey>hid,p35 animals expressing the transgenes 
numbered and listed on the right. All Myo1D transgenes carry a HA-tag at the C-terminus.  
(C) Summary of the rescue experiments of Myo1DK2 and Myo1DEY (Myo1DEy08859) 
mutants with wt and mutant Myo1D transgenes. The key to each genotype is numbered and listed 
on the right. 
(D-I) DHE labeling as ROS marker of eye imaginal discs of indicated genotype. Myo1C 
suppresses Myo1D-induced ROS generation (I). Scale bar: 50μm. 
(J,K) Quantification of the DHE labelings in (D-F) and (G-I). DHE signal intensity was 
determined across the entire discs. 
(L-T) NimC labeling for visualization of hemocytes attached to eye imaginal discs of 
indicated genotype. Note that the activated hemocyte morphology in (L,O,Q) is absent in 
(M,N,P,R,S,T,U). Quantifications in (V) and (W). Scale bars: 20μm. 
 (V,W) Quantification of the NimC labelings in (L-P) and (Q-U) reveals that hemocytes 
recruitment to undead tissue requires the IQ (neck) and tail domains of Myo1D and can be 
antagonized by Myo1C. NimC signal intensity was determined across the entire discs.  
 
Figure 3. Genetic and physical interaction between Myo1D and Dronc. 
(A-D) Head capsule phenotypes of the indicated genotypes. Scale bar: 200μm. 
(E) Extracts from ey>hid,p35,GFP and ey>hid,p35;Myo1D-GFP eye/antennal imaginal 
discs were immunoprecipated with anti-GFP antibodies. Shown are immunoblots of Myo1D-
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GFP immunoprecipitates probed with anti-Dronc (SK11) (top) and anti-GFP antibodies 
(bottom). Arrows indicate Myo1D-GFP and Dronc. 
(F) Extracts from ey-Gal4 (-), ey>Flag-Dronc and ey>Flag-Dronc,Myo1D-HA 
eye/antennal imaginal discs were immunoprecitated with anti-Flag antibodies. Shown are 
immunoblots probed with anti-HA antibodies to visualize Myo1D-HA (top, arrow) and with 
anti-Flag antibodies to reveal Flag-Dronc (bottom). 
(G) Autoradiographs of in vitro cleavage assays of radio-labeled DrICE (positive control) 
and radio-labeled Myo1D by unlabeled active Dronc. Asterisks mark the cleavage products of 
DrICE. 
(H) Immunoblot analysis of total extracts from ey>hid,p35;Myo1D-GFP eye/antennal 
imaginal discs using anti-GFP antibodies. 
 
Figure 4. Myo1D localizes Dronc to the basal side of the plasmamembrane. 
  (A) Left: surface view of the larval eye-antennal imaginal disc at the disc proper (DP) 
level. Right: orthogonal section through the red square along the red dotted line. The peripodial 
membrane (PM; orange) and the DP (green) are separated by a lumen. The apical and basal 
membranes of the DP are indicated by arrows. Hemocytes approach the disc at the DP side. A-
anterior; P-posterior; D-dorsal; V-ventral. 
(B-E’’’) Confocal sections as indicated in the schematic drawing in (A) of eye imaginal 
discs of the indicated genotype labeled for endogenous Myo1D (green), Dronc (red) and Dlg 
(magenta). The discs were processed in parallel and imagined under the same settings. The 
peripodial membrane (PM) and the basal side of the disc proper (DP) are indicated by arrows in 
the sections. Scale bar: 5 m.  
(F) Quantification of the Dronc labelings in (B-E) at the basal side of the 
plasmamembrane of DP cells. Signal intensity was determined only at the basal side of the 
plasmamembrane.  
(G) Immunoblot analysis of total extracts from larval eye imaginal discs of the indicated 
genotype suggests that endogenous Dronc protein is destabilized by absence of Myo1D due to 
Myo1D RNAi (BL33971). 
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(H) Schematic drawings of the morphology of salivary glands in surface view (top) and 
in sections through the middle of the gland (bottom). The basal sides of the plasmamembrane are 
identified by arrows. The apical sides face the lumen of the gland. Nuclei are in blue. The red 
square depicts the view in panels (I-L). 
(I-L’’’) Confocal section views as illustrated by the red square in (H) of larval salivary 
glands of indicated genotypes labeled for endogenous Myo1D (green), Dronc (red), Dlg 
(magenta) and DAPI (blue). The basal sides of the plasmamembrane and the lumen are indicated 
by arrows. The glands were processed in parallel and imagined under the same settings. Scale 
bar: 50 m.   
  (M-O’) Confocal sections according to (A) through eye imaginal discs of the indicated 
genotypes labeled for HA (to detect Myo1D-HA) and endogenous Dronc. Peripodial membrane 
(PM) and basal side of disc proper (DP) are indicated by arrows. 
(P) Quantification of the Dronc labelings in (M’-O’) at the basal side of the 
plasmamembrane of DP cells. Signal intensity was determined only at the basal side of the 
plasmamembrane. 
 
Figure 5. Non-apoptotic activity of Dronc at the plasmamembrane. 
(A-C’’’’) Surface (A-A’’,B-B’’,C-C’’) and section views 
(A’’’,A’’’’,B’’’,B’’’’,C’’’,C’’’’) according to Figure 4A of eye imaginal discs of indicated 
genotype labeled with cleaved caspase3 (CC3, red), the polarity marker Dlg (in A; green) and 
endogenous Myo1D (in B,C; green). Peripodial membrane (PM) and the basal side of the disc 
proper (DP) are indicated by arrows on the right of the sections. In (A), apoptosis was induced 
by shifting to 30°C for 12 hours prior to dissection (Fan et al., 2014). Scale bar: 10μm. 
(D-E’’’) Surface (D-D’’;E-E’’) and section views (D’’’;E’’’) of larval salivary glands 
(SG) according to Figure 4H of the indicated genotype labeled with CC3 and the polarity marker 
Dlg. In the sections, the basal sides of the plasmamembrane and the lumen are indicated by 
arrows. 
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(F,G) Surface views of larval SGs of indicated genotype labeled for CC3 (green), the 
polarity marker Dlg (red) and DAPI (blue). Normal SGs have weak membrane localization of 
CC3 (F’) that is completely lost upon Myo1D RNAi driven by Fkh-Gal4 (G’). Scale bar: 20μm. 
(H) Illustration of the specificities of CC3 and cDcp1 antibodies with respect to the 
apoptotic and non-apoptotic cleavage targets of Dronc. 
(I,K’) droncI24/I24 (I) mutant and dcpPrev/Prev;drICEΔ1/Δ1 (J,K) double mutant SGs labeled 
for CC3 in (I,K), cleaved Dcp1 (cDcp1) in (J), the polarity marker Dlg and DAPI. Scale bars: 
20μm. 
  
Figure 6. Myo1D requires Duox for its function in apoptosis-induced proliferation. 
(A-C) The overgrown head capsule (A) of ey>p35,Myo1D-GFP animals correlates with 
ROS production (DHE labeling in (B))  and activated hemocytes (NimC labeling in (C)) in larval 
imaginal eye discs. Scale bars: 200, 50 and 20 μm in (A), (B) and (C), respectively. 
(D-F) Knockdown of Duox in ey>p35,Myo1D-GFP animals suppresses the overgrowth 
of the head capsule (D), ROS production (E) and hemocytes activation (F). 
(G,H) Quantification of DHE (G) and NimC (H) labelings in (B,E) and (C,F) panels, 
respectively. Signal intensities were determined across entire discs. 
(I-K) Endogenous Duox (magenta) and Dronc (red) proteins co-localize at the PM and 
basal plasmamembrane of DP cells in ey>hid,p35 eye imaginal discs. Scale bar: 10 μm. 
(L-N) Endogenous Duox (magenta) and Dronc (red) proteins co-localize at the basal side 
of the plasmamembrane of larval ey>hid,p35 SG cells. Blue = DAPI (nuclei). Scale bar: 20 μm. 
(O-R) Myo1D and Duox synergize for production of ROS in ey>p35 discs. Scale bar: 50 
μm.  
(S) Quantification of DHE labelings in (O-R). Signal intensities were determined across 
entire discs. ns - not significant. 
(T,U) dronc RNAi suppresses overgrowth of head capsules of (T) and ROS generation in 
eye discs (U) of ey>p35,Myo1D-GFP animals (compare to A,B). 
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Figure 7. Myo1D is required for neoplastic tumor growth and invasion of scrib-/-RasV12 cells. 
scrib-/-RasV12 mutant clones are generated by the MARCM system and are marked by 
GFP. UAS-lacZ was used as control transgene in (A,D,G,J).  
(A-L) Growth of scrib-/-RasV12 clones (A), invasion of mutant tissue into the ventral nerve 
cord (VNC) of the larval brain (D, arrow), generation of ROS (DHE) by scrib-/-RasV12 mosaic 
discs (G) and recruitment and activation (arrows in J) of hemocytes (NimC) to scrib-/-RasV12 
mosaic discs (J) is prevented by Myo1D RNAi (BL33791) (B,E,H,K). OL – optic lobe. 
Quantifications in (C,F,I,L). Signal intensities (GFP, DHE, NimC) were determined across entire 
discs. Scale bars: 50 μm in A,B,G,H,J,K; 100 μm (D,E). 
(M-N’) Membrane association of Dronc protein in scrib-/-RasV12 mutant clones (M’) is 
disrupted by Myo1D RNAi (N’). Scale bars: 20 μm.  
   
Figure 8. Model of Myo1D function in apoptosis-induced proliferation 
The data presented in this paper suggest that Myo1D is required for membrane 
localization of Dronc, specifically to the basal side of the plasmamembrane of undead epithelial 
disc proper and salivary gland cells. Here, Dronc is required for activation of Duox for 
generation of extracellular ROS. Duox-generated ROS attract and activate hemocytes to the 
basal side of disc proper cells of eye imaginal discs. Hemocytes release Eiger to stimulate JNK 
activity and AiP in undead epithelial cells. 
 
 
 
 STAR METHODS 
 
Contact for reagent and resource sharing 
Please contact Andreas Bergmann (andreas.bergmann@umassmed.edu) 
 
Method Details 
 
Genetics and fly stocks 
To test mutants or RNAi lines for involvement in AiP, they were crossed to the ey>hid,p35 stock 
(exact genotype: UAS-hid; ey-Gal4 UAS-p35/CyO,tub-Gal80 (Fan et al., 2014) and the offspring 
was scored for suppression of head capsule overgrowth. Unless otherwise noted, the ey>p35 (ey-
Gal4 UAS-p35/CyO) was used in control crosses. Most crosses were performed with the 
UAS/Gal4 system (Brand and Perrimon, 1993). scrib-/- RasV12 clones were induced using the 
MARCM technique (Lee and Luo, 1999). The scrib2 allele was used. 
Myo1DK2 (a kind gift of S. Noselli (Nice, France)) was obtained by imprecise excision of a P-
allele of Myo1D, Myo1DKG02246, and deletes almost the entire Myo1D locus (Speder et al., 2006). 
Myo1DEy08859 (BL19940) carries a P-element insertion one nucleotide after the transcriptional 
start side. All other stocks are listed in the Key Resources Table 
 
Immunolabeling and DHE stainings 
For labeling with antibodies, fixed eye/antennal imaginal discs were used following standard 
protocols (Fan and Bergmann, 2014; Fogarty and Bergmann, 2014). The anti-Myo1D antibody 
(1:200; Abmart, Shanghai,China) is a monoclonal antibody raised against the 
F526KRLLHNSKDAN epitope in the head domain of Myo1D. Fluorescent secondary antibodies 
were obtained from Jackson ImmunoResearch. DHE labelings were performed on unfixed 
imaginal discs as described previously (Owusu-Ansah et al., 2008).  
 
Co-immunoprecipation (co-IP) and immunoblotting 
Figure 3E: Because the available Myo1D antibody did not perform in IP experiments, UAS-
Myo1D-GFP was crossed into ey>hid,p35 background and IP experiments were performed with 
GFP-Trap_M beads (15μl, Chromotek) from larval extracts. Immunoprecipitates were separated 
on 4-15% gradient SDS-PAGE and blotted on PVDF membranes. GFP (1:1000; Pierce) and 
Dronc (SK11) (1:1000; gift of P. Meier) antibodies were used for immunoblotting. For the 
reverse experiment (Figure 3F), Flag-Dronc and Myo1D-HA were crossed into ey-Gal4 
background and immunoprecipitates using anti-Flag M2 magnetic beads (35μl, Sigma-Aldrich) 
were separated by SDS-PAGE. Immunoblots were probed with HA (1:1000; Pierce) and Flag 
(1:1000, Sigma-Aldrich) antibodies. For Figure 3H, total extracts of ey>hid,p35,Myo1D-GFP 
and ey>hid,p35,Myo1D-GFP,Flag-Dronc imaginal discs were analyzed by immunoblotting with 
GFP antibodies.  
 
In vitro Dronc cleavage assays 
To test if Dronc can proteolytically process Myo1D in vitro, recombinant 6x-His-Dronc protein 
in pET23b (gift of G. Salvesen) was expressed in E.coli strain BL21pLysS(DE3) and purified 
using published protocols (Dorstyn and Kumar, 2008; Kamber Kaya et al., 2017; Snipas et al., 
2008). A significant fraction of Dronc protein undergoes autocleavage and is proteolytically 
active within 24h after preparation. Myo1D and the positive control DrICEC211A (which is a 
Key Resource Table
 catalytic mutant to avoid autoprocessing) were cloned into pBluescript and synthesized in vitro 
as S35-labeled proteins in rabbit reticulocyte lysates (Promega) with T7 polymerase. These 
radiolabeled proteins were incubated with the active Dronc preparations for 90 min at 25°C and 
separated by SDS-Page. Gels were dried and exposed to autoradiography overnight. 
 
Quantification and statistics. 
For quantification of confocal images, the ‘Record Measurement’ function of Photoshop was 
used. Discs were outlined and signal intensity determined. Crosses were repeated at least three 
times. Analysis and graph generation was done using GraphPad Prism 7.03. The statistical 
method used was the student’s T-test, one-tailored distribution, two sample unequal variance, 
unless otherwise indicated. Plotted is mean intensity ± SE. P values: ** P<0.01; *** P<0.001; 
**** P <0.0001. 
N numbers are as follows:  
Figure 1P: n = 4, 15, and 8 for control, ey>hid,p35 and ey>hid, p35;Myo1DRNAi, respectively. 
Figure 1T: n = 6, 9 and 6 for control, ey>hid,p35 and ey>hid, p35;Myo1DRNAi, respectively. 
Figure 2J: n = 5, 5 and 7 (D-F). 
Figure 2K: n = 4, 6 and 6 (G-I). 
Figure 2V: n = 19, 5, 8, 7, 7 (K-O) 
Figure 2W: n = 15, 6, 6, 4, 4 (P-T). 
Figure 4F: n = 10, 6, 10, 4 (B-E). 
Figure 4P: n = 5, 4, 6 (N-O). 
Figure 6G: n = 4, 8, 4 for ey>p35; ey>p35,Myo1D; ey>p35, Myo1D, Duox RNAi, respectively. 
Figure 6H: n = 3, 9, 4 for ey>p35; ey>p35,Myo1D; ey>p35, Myo1D, Duox RNAi, respectively. 
Figure 6S: n = 4, 5, 5, 4 for ey>p35, ey>p35,Myo1D,  ey>p35,Duox,  ey>p35,Myo1D+Duox, 
respectively. 
Figure 7C: n = 9 and 7 for scrib-/-RasV12 and scrib-/-RasV12,Myo1DRNAi. 
Figure 7F: n = 5 and 5 for scrib-/-RasV12 and scrib-/-RasV12,Myo1DRNAi. 
Figure 7I: n = 3 and 4 for scrib-/-RasV12 and scrib-/-RasV12,Myo1DRNAi. 
Figure 7L: n = 5 and 3 for scrib-/-RasV12 and  scrib-/-RasV12,Myo1DRNAi. 
 
  
 KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Mouse monoclonal NimC  (1:300) Kindly provided by I. 
Ando 
(Kurucz et al., 2007) 
Guinea pig Dronc (1:200) Kindly provided by P. 
Meier 
SK11; (Wilson et al., 
2002) 
Rabbit polyclonal Cleaved Caspase 3 (CC3) (1:400) Cell Signaling 
Technology 
Cat#9661S 
Mouse monoclonal Wg (1:50) DSHB Cat#4D4 
Mouse monoclonal Myo1D (1:250) Abmart, Shanghai,China Cat#20735-1-
16/P23_141121 
Rabbit polyclonal Duox (1:100) LS Bio Cat#C410118 
Rabbit polyclonal Cleaved Dcp1 (cDCP1) (1:200) Cell Signaling 
Technology 
Cat#9578S 
Mouse monoclonal β-Gal (1:100) Promega Cat#Z378A 
Rabbit polyclonal Phospho-JNK  (pJNK) (1:200) Promega Cat#V793B 
Mouse monoclonal GFP (Western Blot-1:1000) Pierce Cat#MA15256 
Rat polyclonal ELAV (1:50) DSHB Cat#7EBA10 
Mouse monoclonal HA (1:200, Western Blot-1:2000) Invitrogen Cat#26183 
Mouse monoclonal FLAG (Western Blot-1:1000) Sigma-Aldrich 
 
Cat#F1804 
Bacterial and Virus Strains  
E.coli strain BL21pLysS(DE3) Promega Cat#L1191 
Chemicals, Peptides, and Recombinant Proteins 
DHE Invitrogen Cat#D23107 
Gfp-Trap_M beads Chromotek Cat#Gtm-20 
anti-Flag M2 magnetic beads Sigma-Aldrich Cat#M8823 
6x-His-Dronc protein Kindly provided by 
G.Salvesen 
(Snipas et al., 2008) 
DrICEC211A Kindly provided by 
G.Salvesen 
(Snipas et al., 2008) 
Vectashield with DAPI Vector Laboratories Cat#H-1200 
Critical Commercial Assays 
Rabbit reticulocyte lysates Promega Cat#L4610 
In Situ Cell Death Detection Kit, TMR red Roche Cat#12156792910 
Experimental Models: Organisms/Strains 
UAS-hid; ey-Gal4 UAS-p35/CyO,tub-Gal80  (Fan et al., 2014) 
ey-Gal4 UAS-p35/CyO  (Fan et al., 2014) 
scrib-/- RasV12 Kindly provided by M. Kango-Singh (Chen et al., 2012) 
Myo1D RNAi Bloomington Drosophila Stock Center BDSC33971 
FlyBase: FBst0033971 
Myo1D RNAi Vienna Drosophila RNAi Center v102456 
FlyBase:FBst0475947 
Myo1DK2 Kindly provided by S. Noseli FlyBase:FBal0194493 
(Speder et al., 2006) 
Myo1DEy08859 Bloomington Drosophila Stock Center FlyBase:FBst0019940 
UAS-Myo1D Kindly provided by S. Noseli  (Speder et al., 2006) 
UAS-Myo1D-GFP Kindly provided by S. Noseli (Speder et al., 2006) 
 UAS-Myo1D-HA Kindly provided by K. Matsun, 
 
FlyBase:FBtp0081821 
(Hozumi et al., 2008) 
UAS-Myo1C-HA Kindly provided by K. Matsuno  (Hozumi et al., 2008) 
UAS-Myo1D/1C-HA Kindly provided by K. Matsuno  
 
FlyBase:FBtp0081835 
(Hozumi et al., 2008) 
UAS-Myo1C/1D-HA Kindly provided by K. Matsuno  (Hozumi et al., 2008) 
UAS-Myo1D-HAmATP Kindly provided by K. Matsuno  FlyBase:FBtp0081822 
(Hozumi et al., 2008) 
UAS-Myo1D-HAΔAbs Kindly provided by K. Matsuno  FlyBase:FBtp0081824 
(Hozumi et al., 2008) 
UAS-Myo1D-HAΔIQ Kindly provided by K. Matsuno  
 
FlyBase:FBtp0081825 
(Hozumi et al., 2008) 
UAS-Myo1D-HAΔtail Kindly provided by K. Matsuno FlyBase:FBtp0081826 
(Hozumi et al., 2008) 
UAS-Flag-dronc Bergmann lab FlyBase:FBtp0093662 
(Kamber Kaya et al., 
2017) 
UAS-dark-GFP Kindly provided by H-D Ryoo FlyBase:FBtp0116994 
(Shapiro et al., 2008) 
UAS-dronc RNAi Kindly provided by P. Meier BDSC32963 
FlyBase:FBst0032963 
(Leulier et al., 2006) 
UAS-Duox RNAi Kindly provided by W. J. Lee  FlyBase:FBal0190061 
(Ha et al., 2005) 
UAS-Duox Kindly provided by W. J. Lee FlyBase:FBal0190278 
(Ha et al., 2005) 
droncI24  Bergmann lab FlyBase:FBal0190335 
(Xu et al., 2005) 
dcp1Prev Kindly provided by K. McCall FlyBase:FBal0156746 
(Laundrie et al., 2003) 
drICEΔ1 Kindly provided by B. Hay FlyBase:FBal0193685 
(Muro et al., 2006) 
DE-Gal4 Kindly provided by G. Halder (Morrison and Halder, 
2010) 
UAS-hid/+; DE-Gal4 tub-Gal80ts/+ Bergmann lab (Fan et al., 2014) 
Nub-Gal4  (Calleja et al., 1996) 
GMR-Gal4 UAS-eiger Kindly provided by M. Miura (Igaki et al., 2002) 
UAS-bsk RNAi Vienna Drosophila RNAi Center v34138 
FlyBase:FBst0460476 
UAS-Traf2 RNAi Vienna Drosophila RNAi Center v110266 
FlyBase:FBst0481844 
puc-lacZ   FlyBase:FBal0047865 
(Ring and Martinez 
Arias, 1993) 
GMR-hid Kindly provided by H. Steller FlyBase:FBal0265023 
(Grether et al., 1995) 
UAS-Empty Vector (UAS-EV) Bergmann lab (Kamber Kaya et al., 
2017) 
Canton S  FlyBase:FBst0064349 
w1118  FlyBase:FBst0003605 
 w*; KrIf-1/CyO; M{lexAop-UAS-
GrabFP.A.Int.mCh}ZH-86Fb/TM6B, Tb1 
Bloomington Drosophila Stock Center FlyBase:FBst0068178 
(Harmansa et al., 
2017) 
 
Detailed Genotypes 
Figure Panel Genotype 
1 B, M,M’,Q,V +/+;ey>p35/+;+/+ 
 C,N,N’,R UAS-hid/+;ey>p35/+;+/+ 
 D UAS-hid/+;ey>p35/UAS-Empty Vector (EV);+/+ 
 E UAS-hid/+;ey>p35/UAS-Myo1D RNAi;+/+ 
 F,O,O’,S UAS-hid/+;ey>p35/+;UAS-Myo1D RNAi/+ 
 G UAS-hid/+;ey>p35/Myo1DK2;+/+ 
 H UAS-hid/+;ey>p35/Myo1DEy08859;+/+ 
 I UAS-hid/+;ey>p35/+;UAS-Myo1D/+ 
 J,J’ +/+;ey>p35/+;puc-lacZ/+ 
 K,K’ UAS-hid/+;ey>p35/+;puc-lacZ/+ 
 L,L’ UAS-hid/+;ey>p35/UAS-Myo1D RNAi; puc-lacZ/+ 
 W +/+;ey>p35/+;UAS-Myo1D/+ 
   
2 D,L UAS-hid/+;ey>p35/+;+/+ 
 E,M UAS-hid/+;ey>p35/+;UAS-Myo1DΔIQ-HA/+ 
 F,N UAS-hid/+;ey>p35/UAS-Myo1C-HA;+/+ 
 G,Q +/+;ey>p35/+;UAS-Myo1D-HA/+ 
 H,R +/+;ey>p35/+;UAS-Myo1DΔIQ-HA/+ 
 I,U +/+;ey>p35/UAS-Myo1C-HA;UAS-Myo1D-HA/+ 
 O UAS-hid/+;ey>p35/+;UAS- Myo1CH -Myo1DIQ-tail-HA/+ 
 P UAS-hid/+;ey>p35/+; UAS- Myo1DH -Myo1CIQ-tail-HA /+ 
 S +/+;ey>p35/+;UAS-Myo1DΔtail-HA/+ 
 T +/+;ey>p35/UAS-Myo1C-HA;+/+ 
   
3 A +/+;ey>p35/+;+/+ 
 B +/+;ey>p35/UAS-Flag-Dronc;+/+ 
 C +/+; ey>p35/+;UAS-Myo1D-HA/+ 
 D +/+; ey>p35/UAS-Flag-Dronc;UAS-Myo1D-HA/+ 
 E lane 1: UAS-hid/+;ey>p35/+;UAS-GFP/+ 
lane 2: UAS-hid/+;ey>p35/+;UAS-Myo1D-GFP/+ 
 F lane 1: +/+;ey-Gal4/+;+/+ 
lane 2: +/+;ey-Gal4/UAS-Flag-dronc;+/+ 
lane 3: +/+;ey-Gal4/UAS-Flag-dronc;UAS-Myo1D-HA/+ 
 H lane 1: UAS-hid/+;ey>p35/+; UAS-Myo1D-GFP/+ 
lane 2: UAS-hid/+;ey>p35/UAS-Flag-dronc; UAS-Myo1D-GFP/+ 
   
4 B-B’’,I-I’’’ +/+;ey-Gal4/+;+/+ 
 C-C’’,J-J’’’ +/+;ey-Gal4/+;UAS-Myo1D RNAi/+ 
 D-D’’,K-K’’’ UAS-hid/+;ey>p35/+;+/+ 
 E-E’’,L-L’’’ UAS-hid/+;ey>p35/+; UAS-Myo1D RNAi /+ 
 G lane 1: UAS-hid/+;ey>p35/UAS-Flag-Dronc;+/+   
lane 2: UAS-hid/+;ey>p35/UAS-Flag-Dronc;UAS-Myo1D RNAi/+   
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Supplemental figures and legends 
 
 
Figure S1. Information related to Figure 1. 
(A-D) Representative examples of the phenotypic classes of ey>hid,p35-induced overgrowth of 
the head capsules. Overgrowth was scored based on qualitative screening criteria as (B) weak 
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(presence of additional bristles and ocelli), (C) moderate (expansion of head capsule width) or 
(D) severely overgrown (strong amorph head capsule overgrowth at the expense of eyes). (A) 
wild-type fly head. 
(E-F’’) The eye ablation phenotype of GMR-hid (E) is caused by two apoptotic waves (arrows) 
in the eye imaginal disc (E’’; arrows; CC3-cleaved caspase3) (Fan and Bergmann, 2014). 
Myo1D RNAi in the dorsal half of the GMR-hid eye disc using dorsal eye- (DE-)Gal4 does not 
modify the eye phenotype (F) nor the cell death pattern in the eye disc (F’’). The DE-Gal4 driver 
is expressed dorsally as indicated by GFP expression (green) (E’,F’) and the yellow line in 
(E’’,F’’). Elav labels photoreceptor neurons (blue in E’,F’). 
(G-I’) Cleaved caspase 3 (CC3, green) and TUNEL labeling (red) of apoptotic (nub>hid) wing 
imaginal discs of indicated genotype. While p35 expression suppresses TUNEL-labeling of 
apoptosis (I,I’), Myo1D RNAi does not (H,H’).CC3 labeling persists in undead (p35-inhibited)  
nub>hid wing imaginal discs (I), but shifts towards the basal side of the plasmamembrane of disc 
proper (DP) cells (inset in I). 
(J-K’) The strong Wg labeling (red) in ey>hid,p35 eye discs (J,J’) is significantly reduced by 
Myo1D RNAi line KK102456 (K,K’). 
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Figure S2. Myo1D is not acting in the Eiger signaling pathway. (Related to Figure 1) 
Myo1D RNAi (KK102456) (C) is unable to suppress the strong eye ablation phenotype caused 
by GMR-Eiger (B) in contrast to Traf2 RNAi (D) and JNK RNAi (E) which are known players 
in Eiger signaling (A). 
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Figure S3. Misexpression of Myo1D in ey>p35 eye imaginal discs induces JNK activity 
(pJNK) and increased Wg protein expression. (Related to Figure 1) 
(A-B’) Misexpression of Myo1D in ey>p35 eye/antennal imaginal discs induces strong JNK 
activity (pJNK) (B,B’) and overgrown discs compared to ey>p35 control discs (A,A’). 
(C-D’) Misexpression of Myo1D in ey>p35 eye/antennal imaginal discs induces strong Wg 
expression (D,D’) and overgrown discs compared to ey>p35 control discs (C,C’). 
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Figure S4. Specific requirement of neck (IQ) and tail domains for Myo1D’s function in AiP. 
(Related to Figure 2)  
(A-F) Head capsules of ey>hid,p35 (A) flies expressing the indicated  transgenes (B-F). 
(G-J) Head capsules of ey>p35 (G) flies expressing the indicated transgenes (H-J). 
(K) Immunoblot analysis to examine expression levels of indicated wild-type and mutant 
Myo1D-HA, Myo1C-HA and chimeric transgenes in ey>hid,p35 background. In each lane, 
extracts of four adult heads were loaded. The blot was probed with anti-HA antibody. A loading 
control blot was probed with anti-Actin antibody. Three independent immunoblot experiments 
gave comparable results. 
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Figure S5. Mis-localization of Dronc by apical targeting of Myo1D-GFP with GrapFP-AInt. 
(Related to Figure 4) 
(A-A’’) Sections of undead (ey>hid,p35) eye imaginal disc co-expressing UAS-Myo1D-GFP 
labeled for endogenous Dronc protein (magenta) and Myo1D-GFP (green). Dronc protein is 
localized at the peripodial membrane (PM) and the basal side of the plasmamembrane of the disc 
proper (DP) (arrows).  
(B-B’’’) Sections of undead (ey>hid,p35) eye imaginal disc co-expressing UAS-Myo1D-GFP 
and UAS-GrabFP-AInt labeled for endogenous Dronc protein (magenta), Myo1D-GFP (green) 
and GrabFP-AInt (red). GrabFP-AInt encodes an apically-localized GFP-specific nanobody that 
targets GFP-containing fusion proteins to the apical side of the plasmamembrane (Harmansa et 
al., 2017). Although GrabFP-AInt protein does not perfectly localize to the apical side of the 
plasmamembrane (B’’’), it disrupts the basal localization of Myo1D-GFP (B’’). Consequently, 
the basal localization of Dronc is also abolished (B’).  
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Figure S6. Subcellular localization of Dark-GFP is not changed in undead salivary gland 
(SG) cells and is not dependent on Myo1D. (Related to Figure 4) 
Shown are confocal sections through the middle of SGs. Basal sides of SG cells and the lumen 
between them are indicated by arrows. DAPI (blue) labels nuclei. 
(A) The subcellular localization of Dark-GFP (green) in control (ey-Gal4) SG cells. Scale bar: 
20μm. 
(B) The subcellular localization of Dark-GFP in undead (ey>hid,p35) SG cells is not 
significantly changed compared to (A). 
(C) The subcellular localization of Dark-GFP in undead (ey>hid,p35) SG cells expressing 
Myo1D RNAi (BL33971) is not significantly changed compared to (B). 
(D-D’’) Comparison of the localization of endogenous Dronc (red) and mis-expressed Dark-GFP 
(green) proteins in undead larval SG cells. Dark-GFP labeling is cytosolic in SG cells, but also 
has a low level localization at the plasmamembrane, although it is very low at the basal side (D, 
D’) where Dronc is localized (D’’). Scale bar: 20 μm. 
